Home > Drug Search >
  • company_query: Akari
  •   > 
Drug Filter
Category:
chemistry (2) biology (37)
Status:
Approved (10) BLA Filing (4) Phase Ⅲ (2) Phase Ⅱ (12) Phase Ⅰ (11)
Clinical Stage:
Pending (2) Active (27)
Bio-Type:
Vaccine (1) Recombinant enzyme (3) Recombinant cytokines (11) Recombinant hormone (2) Whole antibody (9) Fab fragment (1) ADC (1) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Acute lymphoblastic leukaemia (ALL) (2) Acute myeloid Leukemia (AML) (2) Anemia (4) Atopic dermatitis (1) Bladder cancer (2) Breast cancer (1) Chronic immune thrombocytopenia (1) Central nervous system cysticercosis (1) Cutaneous T cell lymphoma (CTCL) (1) Urogenital cancer (1) Gastric cancer (1) Wet age-related macular degeneration (1) HBV infection (4) HCV infection (4) Alcoholic hepatitis (1) Chemotherapy-induced thrombocytopenia (1) Tumour lysis syndrome (1) Leukemia (1) Lung cancer (2) Lymphoma (3) Melanoma (2) Haematological disorders (1) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (1) Non-Hodgkin’s lymphoma (NHL) (3) Pancreatic cancer (1) Psoriasis (1) Rheumatoid arthritis (RA) (2) Fabry disease (1) Colorectal cancer (3) Paroxysmal Nocturnal Hemoglobinuria (PNH) (1) Anthrax (1) Neuroblastoma (1) Anaplastic astrocytoma (1) Autistic disorder (1) Hypophosphatasia (1) Neutropenia (2) Condylomata acuminata (1) Infertility (1) Peritoneum cancer (1) Glioblastoma (2) Plaque psoriasis (1) Gout (1) Acute kidney injury (1) hematological malignancies (1)
Country:
Aprv. Year:
2005 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top